Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
May 2020
Historique:
received: 05 03 2020
revised: 30 03 2020
accepted: 31 03 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 4 6 2020
Statut: ppublish

Résumé

This study evaluated the prognostic significance of preoperative neutrophil-to-lymphocyte ratio (NLR) and CD8 A total of 154 patients with BTCs who underwent surgery were enrolled in this study. We obtained neutrophil and lymphocyte counts, and calculated NLR from preoperative peripheral blood samples. CD8 The overall survival (OS) and recurrence-free survival (RFS) of patients with high NLR were shorter than those with low NLR. The OS and RFS of patients with high CD8 NLR and CD8

Sections du résumé

BACKGROUND/AIM OBJECTIVE
This study evaluated the prognostic significance of preoperative neutrophil-to-lymphocyte ratio (NLR) and CD8
PATIENTS AND METHODS METHODS
A total of 154 patients with BTCs who underwent surgery were enrolled in this study. We obtained neutrophil and lymphocyte counts, and calculated NLR from preoperative peripheral blood samples. CD8
RESULTS RESULTS
The overall survival (OS) and recurrence-free survival (RFS) of patients with high NLR were shorter than those with low NLR. The OS and RFS of patients with high CD8
CONCLUSION CONCLUSIONS
NLR and CD8

Identifiants

pubmed: 32366438
pii: 40/5/2881
doi: 10.21873/anticanres.14264
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2881-2887

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Ryota Tanaka (R)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Kenjiro Kimura (K)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan kenjiro@med.osaka-cu.ac.jp.

Shinpei Eguchi (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Jun Tauchi (J)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Masatune Shibutani (M)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Hiroji Shinkawa (H)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

G O Ohira (GO)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Sadaaki Yamazoe (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Shogo Tanaka (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Ryosuke Amano (R)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Hiroaki Tanaka (H)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Masakazu Yashiro (M)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
Molecular Oncology and Therapeutics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Cancer Center for Translational Research, Osaka City University Graduate School of Medicine, Osaka, Japan.

Shoji Kubo (S)

Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Masaichi Ohira (M)

Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH